title: The impact of mergers on pharmaceutical R&D.
abstract: Mergers and acquisitions in the pharmaceutical industry have substantially reduced the number of major companies over the past 15 years. The short-term business rationale for this extensive consolidation might have been reasonable, but at what cost to research and development productivity?
authors.affiliation: Puretech Ventures, Boston, Massachusetts 02116, USA. john.lamattina@comcast.net
authors.forename: John L
authors.initials: JL
authors.lastname: LaMattina
mesh_terms: D004345:Drug Industry / Q000191:economics / Q000458:organization & administration*; D012106:Research / Q000191:economics / Q000458:organization & administration*